Phillip Say, MD
Otolaryngology · Las Vegas, NVNPI 1972591899
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.6% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 34.4% of the total. 2025 is the largest year on record at $918, more than ten times the $55 reported in 2019.
Across 98 payments — averaging $24.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$837
- Optinose US, Inc.$657
- GSK$316
- Sanofi$263
- Stryker$128
- Sanofi-aventis U.S. LLC$99
- plus $135 from 6 others
What the payments were for
- Food & beverage$2,27994%
- Education$1556%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 23 | $837 |
| Optinose US, Inc. | 36 | $657 |
| GSK | 15 | $316 |
| Sanofi | 13 | $263 |
| Stryker | 3 | $128 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Medtronic | 2 | $40 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Itamar Medical Inc | 1 | $20 |
| Amgen | 1 | $20 |
| Intersect ENT, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$242
How this compares
$2,434 in reported general payments places this provider in the 55th percentile of 41 otolaryngology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 187 | $3,212 |
| Ipratropium Bromide | 97 | $2,289 |
| Triamcinolone Acetonide | 12 | $1,643 |
| Azelastine Hcl | 42 | $1,491 |
| Ofloxacin | 40 | $1,456 |
| Pantoprazole Sodium | 66 | $563 |
| Fluocinolone Acetonide Oil | 11 | $377 |
| Montelukast Sodium | 23 | $301 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $218 |
| Omeprazole | 20 | $185 |
| Mometasone Furoate | 22 | $171 |
| Methylprednisolone | 30 | $157 |
| Fluconazole | 13 | $117 |
| Clonazepam | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Las Vegas
- Oluwafunmilola OkuyemiLas Vegas$60K
- Jeannie KhavkinLas Vegas$22K
- Robert WangLas Vegas$9K
- Suparna ShahLas Vegas$8K
- Candice YipLas Vegas$5K
- Daniel HiltonLas Vegas$5K
- Steven BeckerLas Vegas$4K
- Harry ChingLas Vegas$4K
- Lenhanh TranLas Vegas$3K
- Sean PalaciosLas Vegas$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.